Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BioNexus Gene Lab(BGLC) the Revenue is 76.16 K (-96.63%);the EBIT is -303.63 K (+51.22%);the EPS is -0.118 (+65.45%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B96.63%
----
----
EBIT
-0.00B51.22%
----
----
EPS
-0.118565.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf